Spiriva respimat and Ranexa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Spiriva respimat (tiotropium bromide) and Ranexa (ranolazine). Common drug interactions include nausea among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Spiriva respimat and Ranexa. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Spiriva respimat?

Spiriva respimat has active ingredients of tiotropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 9,788 Spiriva respimat users. Check the latest studies of Spiriva respimat.

What is Ranexa?

Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.



On Aug, 02, 2026

17 people who take Spiriva respimat and Ranexa together, and have interactions are studied.

Spiriva respimat and Ranexa drug interactions.

What are the common drug interactions of Spiriva Respimat and Ranexa, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Death
  3. Intervertebral disc degeneration (spinal disc degeneration)
  4. Syncope (loss of consciousness with an inability to maintain postural tone)
  5. Blood pressure increased
  6. Headache (pain in head)
  7. Dizziness
  8. Anxiety
  9. Colitis ulcerative (inflammation of colon with ulcer)
  10. Constipation

male:

  1. Death
  2. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  3. Hospitalisation
  4. Joint injury
  5. Rectal haemorrhage (bleeding from anus)
  6. Abdominal pain upper
  7. Back injury
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Diarrhoea
  10. Eye irritation

What are the common drug interactions of Spiriva Respimat and Ranexa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Blood pressure increased
  3. Colitis ulcerative (inflammation of colon with ulcer)
  4. Constipation
  5. Headache (pain in head)
  6. Heart rate decreased
  7. Heart rate increased
  8. Influenza like illness
  9. Kidney infection
  10. Lethargy (tiredness)

50-59:

n/a

60+:

  1. Death
  2. Intervertebral disc degeneration (spinal disc degeneration)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Back injury
  5. Balance disorder
  6. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Decreased appetite
  9. Diarrhoea
  10. Disease progression

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 23.53%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 17.65%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 17.65%
  4. Pain: 2 people, 11.76%
  5. Heart Disease: 2 people, 11.76%
  6. High Blood Cholesterol: 2 people, 11.76%
  7. Enlarged Prostate: 2 people, 11.76%
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 11.76%
  9. Pharyngitis (inflammation of the pharynx, causing a sore throat): 2 people, 11.76%
  10. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Spiriva respimat and Ranexa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Spiriva respimat and Ranexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Spiriva respimat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ranexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spiriva respimat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tiotropium bromide and ranolazine (the active ingredients of Spiriva respimat and Ranexa, respectively), and Spiriva respimat and Ranexa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: